Friday 6 November 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.

Revenue: +19.2%
EPS: +64.1%
Free cash flow: −29.8%
Total debt: −5.19%

Quarter to September 2026, against a year earlier

146.38 9.74 −6.24%

Follow PODD

Alert me

Market cap: $10.8B
P/E: 25.2×
Fwd P/E: 24.4×
Dividend yield: —
F-score: 6/9
Altman Z: 9.09
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Insulet Corporation 10-K filed Feb 21, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Feb 21, 2025 · accepted 5:36 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 7, Management’s Discussion and Analysis: no comparison — no earlier filing on file